Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X0XV
|
||||
Former ID |
DNC013281
|
||||
Drug Name |
Dmt-Pro-Dmp-Phe-NH2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528832] | ||
Structure |
Download2D MOL |
||||
Formula |
C36H45N5O5
|
||||
Canonical SMILES |
CC1=C(C(=CC=C1)C)CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C<br />3CCCN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N
|
||||
InChI |
1S/C36H45N5O5/c1-21-10-8-11-22(2)28(21)20-31(34(44)39-30(33(38)43)18-25-12-6-5-7-13-25)40-35(45)32-14-9-15-41(32)36(46)29(37)19-27-23(3)16-26(42)17-24(27)4/h5-8,10-13,16-17,29-32,42H,9,14-15,18-20,37H2,1-4H3,(H2,38,43)(H,39,44)(H,40,45)/t29-,30-,31-,32-/m0/s1
|
||||
InChIKey |
KIPQYPCUMMQKJB-YDPTYEFTSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528832] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528832] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528832] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.